KARBE FRANK (Chief Financial Officer) reported 1 transaction at CIDARA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/12/2025ACC: 0001610618-25-000102
Officer· Chief Financial Officer
Since Feb 2025
-7.29K
Net shares
Net seller
$1.60M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.29K
Price / share
$219.60
Trade value
$1.60M
% of position
12.6%
12/10/2025
57.85K→50.56K
Total
Net shares
−7.29K
Net value
-$1.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2025 | F · Tax Withholding | −7.29K | $219.60 | $1.60M | 12.6% | 57.85K | 50.56K |
| Total | −7.29K | -$1.60M | ||||||
Derivative Transactions0
No derivative transactions reported